Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07092059 · ClinicalTrials.gov registry record · NA
Smartphone Services for Stimulant Use Disorder
A NA study of Stimulant Use Disorder, sponsored by DynamiCare Health.
- Recruiting
- Registry status
- NA
- Development phase
- 270
- Enrollment target
- 1
- Study location
NCT07092059 is a NA study of Stimulant Use Disorder that is actively recruiting participants, run by DynamiCare Health. The registered enrollment target is 270 participants, above the 181-participant average among 9 other Stimulant Use Disorder trials with a reported enrollment target (49% higher). The trial reports 1 study location across 1 state.
The verdict
NCT07092059, a NA study of Stimulant Use Disorder, is actively recruiting participants, sponsored by DynamiCare Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 270 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is testing two approaches to treating Stimulant Use Disorder, or problems with cocaine, crack, methamphetamine, etc. Stimulant Use Disorder is a national epidemic in the U.S. but there is no FDA-approved medication to treat it. There is a behavioral approach that has been found to be the most effective treatment for Stimulant Use Disorder, but this study is testing whether this can be delivered by a smartphone service, remotely, such as at home.
Conditions Studied
Interventions
- DEVICE Smartphone digital therapeutic system
Study Locations (1)
Massachusetts
- This is an At-Home Study - no travel or on-site visits are needed at all; Main Office: 6 Liberty Sq, #2102 - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 270 participants |
| Start Date | 2025-06-24 |
| Est. Completion | 2027-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07092059
The ClinicalTrials.gov registry entry for NCT07092059 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 270 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 181-participant average among 9 other Stimulant Use Disorder trials with a reported enrollment target (49% higher). The listed sponsor is DynamiCare Health, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Stimulant Use Disorder appearing as the primary indexed condition, and to 1 intervention - of which Smartphone digital therapeutic system is the first listed.
NCT07092059 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT07092059 about?
NCT07092059 is a clinical study titled "Smartphone Services for Stimulant Use Disorder". This study is testing two approaches to treating Stimulant Use Disorder, or problems with cocaine, crack, methamphetamine, etc. Stimulant Use Disorder is a national epidemic in the U.S. but there is no FDA-approved medication to treat it. There is a behavioral approach that has been found to be the ...
What is the current status of trial NCT07092059?
This trial is currently recruiting. It is a NA study. The enrollment target is 270 participants. The study started on 2025-06-24. Estimated completion is 2027-08.
What conditions does trial NCT07092059 study?
This clinical trial studies the following conditions: Stimulant Use Disorder.
What interventions are being tested in trial NCT07092059?
The interventions under investigation include: Smartphone digital therapeutic system (DEVICE).
Who is sponsoring clinical trial NCT07092059?
This trial is sponsored by DynamiCare Health, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07092059 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stimulant Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
reSET for the Treatment of Stimulant Use in HIV Clinics: Care Optimization Supporting Treatment Adherence (COSTA)
RECRUITING · NA
-
Continuum of Care in Hospitalized Patients With Opioid/Stimulant Use Disorder and Infectious Complications From Drug Use
RECRUITING · NA
-
Addressing Risk Through Community Treatment for Infectious Disease and Opioid Use Disorder Now (ACTION) Among Justice-involved Populations
ACTIVE NOT RECRUITING · NA
-
Contingency Management for Opioid and Stimulant Use Disorders in Primary Care
ACTIVE NOT RECRUITING · NA
-
Orexin Receptor Antagonism and Sleep in Stimulant Use Disorder
RECRUITING · Phase 2
-
Optimizing Transcranial Magnetic Stimulation for Stimulant Use Disorder
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.